{
    "symbol": "BIOC",
    "name": "Biocept, Inc.",
    "sector": "Healthcare",
    "industry": "Diagnostics & Research",
    "country": "USA",
    "exchange": "NASD",
    "statements": {
        "Income Statement": {
            "Dates": [
                "TTM",
                "12/31/2021",
                "12/31/2020",
                "12/31/2019",
                "12/31/2018",
                "12/31/2017",
                "12/31/2016",
                "12/31/2015"
            ],
            "Total Revenue": [
                "50.12",
                "61.25",
                "27.46"
            ],
            "Cost of Revenue": [
                "34.17",
                "37.76",
                "21.34"
            ],
            "Gross Profit": [
                "15.95",
                "23.48",
                "6.12"
            ],
            "Selling General and Administrative": [
                "25.77",
                "20.93",
                "16.37"
            ],
            "Research and Development": [
                "6.42",
                "4.96",
                "5.22"
            ],
            "Unusual Expense/Income": [
                "",
                "",
                ""
            ],
            "Total Operating Expense": [
                "67.33",
                "63.66",
                "42.93"
            ],
            "Operating Income": [
                "-17.21",
                "-2.41",
                "-15.47"
            ],
            "Interest Income Net": [
                "-0.34",
                "-0.29",
                "-0.24"
            ],
            "Other Income Net": [
                "",
                "0.00",
                "-2.10"
            ],
            "Net Income Before Taxes": [
                "-17.46",
                "-2.70",
                "-17.81"
            ],
            "Provision for Income Taxes": [
                "0.12",
                "0.12",
                "0.00"
            ],
            "Net Income": [
                "-17.59",
                "-2.82",
                "-17.81"
            ],
            "Income Avail. to Common Excl. Extraord.": [
                "-17.59",
                "-2.82",
                "-17.81"
            ],
            "Income Avail. to Common Incl. Extraord.": [
                "-17.59",
                "-2.82",
                "-17.81"
            ],
            "Diluted Average Shares": [
                "16.90",
                "14.78",
                "11.85"
            ],
            "Diluted EPS Excl. Extraord.": [
                "-1.04009",
                "-0.19112",
                "-1.50353"
            ],
            "Diluted EPS Incl. Extraord.": [
                "-1.04009",
                "-0.19112",
                "-1.50353"
            ]
        },
        "Balance Sheet": {
            "Dates": [
                "TTM",
                "12/31/2021",
                "12/31/2020",
                "12/31/2019",
                "12/31/2018",
                "12/31/2017",
                "12/31/2016",
                "12/31/2015"
            ],
            "Total Revenue": [
                "50.12",
                "61.25",
                "27.46"
            ],
            "Cost of Revenue": [
                "34.17",
                "37.76",
                "21.34"
            ],
            "Gross Profit": [
                "15.95",
                "23.48",
                "6.12"
            ],
            "Selling General and Administrative": [
                "25.77",
                "20.93",
                "16.37"
            ],
            "Research and Development": [
                "6.42",
                "4.96",
                "5.22"
            ],
            "Unusual Expense/Income": [
                "",
                "",
                ""
            ],
            "Total Operating Expense": [
                "67.33",
                "63.66",
                "42.93"
            ],
            "Operating Income": [
                "-17.21",
                "-2.41",
                "-15.47"
            ],
            "Interest Income Net": [
                "-0.34",
                "-0.29",
                "-0.24"
            ],
            "Other Income Net": [
                "",
                "0.00",
                "-2.10"
            ],
            "Net Income Before Taxes": [
                "-17.46",
                "-2.70",
                "-17.81"
            ],
            "Provision for Income Taxes": [
                "0.12",
                "0.12",
                "0.00"
            ],
            "Net Income": [
                "-17.59",
                "-2.82",
                "-17.81"
            ],
            "Income Avail. to Common Excl. Extraord.": [
                "-17.59",
                "-2.82",
                "-17.81"
            ],
            "Income Avail. to Common Incl. Extraord.": [
                "-17.59",
                "-2.82",
                "-17.81"
            ],
            "Diluted Average Shares": [
                "16.90",
                "14.78",
                "11.85"
            ],
            "Diluted EPS Excl. Extraord.": [
                "-1.04009",
                "-0.19112",
                "-1.50353"
            ],
            "Diluted EPS Incl. Extraord.": [
                "-1.04009",
                "-0.19112",
                "-1.50353"
            ]
        },
        "Cash Flow": {
            "Dates": [
                "TTM",
                "12/31/2021",
                "12/31/2020",
                "12/31/2019",
                "12/31/2018",
                "12/31/2017",
                "12/31/2016",
                "12/31/2015"
            ],
            "Total Revenue": [
                "50.12",
                "61.25",
                "27.46"
            ],
            "Cost of Revenue": [
                "34.17",
                "37.76",
                "21.34"
            ],
            "Gross Profit": [
                "15.95",
                "23.48",
                "6.12"
            ],
            "Selling General and Administrative": [
                "25.77",
                "20.93",
                "16.37"
            ],
            "Research and Development": [
                "6.42",
                "4.96",
                "5.22"
            ],
            "Unusual Expense/Income": [
                "",
                "",
                ""
            ],
            "Total Operating Expense": [
                "67.33",
                "63.66",
                "42.93"
            ],
            "Operating Income": [
                "-17.21",
                "-2.41",
                "-15.47"
            ],
            "Interest Income Net": [
                "-0.34",
                "-0.29",
                "-0.24"
            ],
            "Other Income Net": [
                "",
                "0.00",
                "-2.10"
            ],
            "Net Income Before Taxes": [
                "-17.46",
                "-2.70",
                "-17.81"
            ],
            "Provision for Income Taxes": [
                "0.12",
                "0.12",
                "0.00"
            ],
            "Net Income": [
                "-17.59",
                "-2.82",
                "-17.81"
            ],
            "Income Avail. to Common Excl. Extraord.": [
                "-17.59",
                "-2.82",
                "-17.81"
            ],
            "Income Avail. to Common Incl. Extraord.": [
                "-17.59",
                "-2.82",
                "-17.81"
            ],
            "Diluted Average Shares": [
                "16.90",
                "14.78",
                "11.85"
            ],
            "Diluted EPS Excl. Extraord.": [
                "-1.04009",
                "-0.19112",
                "-1.50353"
            ],
            "Diluted EPS Incl. Extraord.": [
                "-1.04009",
                "-0.19112",
                "-1.50353"
            ]
        }
    }
}